LADENBURG THALMANN FINANCIAL SERVICES INC. - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 50 filers reported holding CLEARSIDE BIOMEDICAL INC in Q2 2024. The put-call ratio across all filers is 0.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
LADENBURG THALMANN FINANCIAL SERVICES INC. ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2019$7,000
+250.0%
2,4000.0%0.00%
Q3 2019$2,0000.0%2,4000.0%0.00%
Q2 2019$2,000
-33.3%
2,4000.0%0.00%
Q1 2019$3,0000.0%2,4000.0%0.00%
Q4 2018$3,000
-80.0%
2,4000.0%0.00%
Q3 2018$15,000
-42.3%
2,4000.0%0.00%
Q2 2018$26,0000.0%2,4000.0%0.00%
Q1 2018$26,000
+85.7%
2,400
+20.0%
0.00%
Q4 2017$14,0002,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q2 2024
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,940,880$15,411,0002.24%
AWM Investment Company, Inc. 682,434$5,418,0000.51%
NEXTHERA CAPITAL LP 120,763$959,0000.49%
SPHERA FUNDS MANAGEMENT LTD. 300,000$2,382,0000.47%
Rock Springs Capital Management LP 935,000$7,424,0000.43%
ACUTA CAPITAL PARTNERS, LLC 175,000$1,390,0000.33%
Perceptive Advisors 712,062$5,653,0000.32%
Hillhouse Capital Management 854,900$6,788,0000.13%
Ausdal Financial Partners, Inc. 11,800$94,0000.04%
Granite Investment Partners, LLC 53,176$423,0000.03%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders